HR Execs on the Move

Families First Pediatrics

www.ffpeds.com

 
With locations in South Jordan & Riverton Utah, our experienced pediatricians & caring team of professionals provides comprehensive care for your children.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.ffpeds.com
  • 1268, South Jordan Parkway
    South Jordan, UT USA 84095
  • Phone: 801.987.8541

Executives

Name Title Contact Details
Lance Sorenson
Chief Financial Officer Profile

Similar Companies

SourceMark

A certified minority-owned business, SourceMark continues to focus on your needs to improve the lives of all patients, customers, and healthcare providers. Our clinical advisory groups are personally involved with the continued improvement of current p...

Harsha Behavioral Center

Harsha Behavioral Center is a freestanding acute psychiatric care hospital serving children, adolescents, adults, and geriatrics in the Wabash Valley, Vigo County area in and around Terre Haute, Indiana. Harsha Center, Paras Harshawat M.D.

Akorn

At Akorn, we develop, manufacture and market specialty pharmaceuticals, including prescription, consumer health and animal health products. As an industry leader in branded and generic products in alternate dosage forms such as ophthalmics, injectables, oral liquids, otics, topicals, inhalants and nasal sprays, we focus each day on our mission to improve lives, through the quality, availability and affordability of our products. Akorn has Research and Development facilities in Vernon Hills, IL and Cranbury, NJ that provide a robust and continuous pipeline of new products. Akorn`s manufacturing facilities are located in Decatur, IL; Somerset, NJ; Amityville, NY and Hettlingen, Switzerland. In anticipation of long-term, substantial growth, we offer challenging, attractive career opportunities along with competitive salaries and comprehensive benefits. Akorn is an Equal Opportunity Employer. M/F/V/D.

Aclaris Therapeutics

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of drug candidates powered by a robust R&D engine exploring protein kinase regulation.